Skip to content
DeepViews

Vantage Corp (VNTG) — Analysis Summary

Vantage Corp (VNTG) has a market cap of $20.04M with year-over-year revenue growth of -4.4%. Net margin stands at -7.4%. The stock trades at a P/E ratio of -15.2.

Key Takeaways

  • Revenue changed -4.4% year-over-year
  • Net margin of -7.4%
  • P/E ratio of -15.2

Compared with its sector, VNTG posted revenue growth of -4.4% and trades at a P/E of -15.2.

[XASE]

Vantage Corp (VNTG)

$0.65

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$20.04M
Enterprise Value
$11.18M
P/E Ratio
-15.2
Div Yield
0.00%
EV/EBITDA
-47.4
Company Profile
About
About Vantage Corp

Vantage Corp specializes in providing comprehensive shipbroking services, including operational support and consultancy services, tailored to the tanker markets. The company has divided the services into various division such as Freight commission, Demurrage commission, Deviation and other commission and Sales of vessel commission. The company operates as one operating segment and one reportable segment, consisting of the provision of shipbroking services.

Employees

77

Exchange

XASE

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat

At least 3 years of annual financial data required to assess competitive moat.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$9.94M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$8.86M

Cash Flow

Operating Cash Flow$-4.45M
Free Cash Flow$-4.66M
FCF Margin-26.12%
P/FCF Ratio-4.30
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.